Predicting cirrhosis and clinical outcomes in patients with advanced chronic hepatitis C with a panel of genetic markers (CRS7).

doi:10.1097/FPC.0b013e32834c3e74

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Back to search

Article

Predicting cirrhosis and clinical outcomes in patients with advanced chronic hepatitis C with a panel of genetic markers (CRS7).

Pharmacogenetics and genomics - 1 Dec 2011

Curto Teresa M, Lagier Robert J, Lok Anna S, Everhart James E, Rowland Charles M, Sninsky John J

Abstract excerpt

OBJECTIVES: Genetic factors may play a role in fibrosis progression in patients with chronic hepatitis C (CHC). A cirrhosis risk score (CRS7) with seven single nucleotide polymorphisms was previously shown to correlate with cirrhosis in patients with CHC. This study aimed to assess the validity o...

Topics

Antiviral Agents
Carcinoma, Hepatocellular
Cohort Studies
Disease Progression
Female
Genetic Markers
Hepatitis C, Chronic
Humans
Interferon-alpha
Liver Cirrhosis
Liver Neoplasms
Male
Middle Aged
Polyethylene Glycols
Polymorphism, Single Nucleotide

Source

Open in PubMed Open full text

Identifiers

PMID: 21946897
DOI: 10.1097/FPC.0b013e32834c3e74
PMCID: PMC3215092

Genes

AZIN1

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 30 Aug 2026. Prepared record publication-21946897-2026-08-30.1. Manifest publication-graph-cohort-2026-08-30.1.

Source receipt: PubMed via Helena Literature Corpus, retrieved 30 Aug 2026.

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

discussions

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Prospective Studies

Recombinant Proteins

Treatment Outcome